DOE tackles U.S. tracer facility
The U.S. Department of Energy this month issued a request forproposal for project definition studies of a National BiomedicalTracer Facility (NBTF). The facility would create a domestic sourcefor radioisotopes produced by linear accelerators (SCAN
The U.S. Department of Energy this month issued a request forproposal for project definition studies of a National BiomedicalTracer Facility (NBTF). The facility would create a domestic sourcefor radioisotopes produced by linear accelerators (SCAN 4/21/93).
Nuclear medicine advocates claim that the NBTF is needed becauseof a shortage of domestically-produced radioisotopes. They successfullylobbied Congress to order the DOE to appropriate $2 million tofund the project definition studies, which would examine variousfactors involved in building the NBTF, such as cost, locationand construction schedule. The $2 million appropriation is likelyto be approved shortly.
The DOE is expected to approve five applications for fundingproject definition studies, with federal funding amounting to$300,000 per study. Applications must be received by Feb. 1, 1994.
The request for proposal was published in the Oct. 14 issueof the Federal Register.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
